SAB Biotherapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| LMR PARTNERS LLP | 11/14/2025 | 539.59 K | $12.63 K | 0.00% | 5.81% |
| MORGAN STANLEY | 11/14/2025 | 146.44 K | $3.43 K | 0.00% | 1.58% |
| CLEAR STREET GROUP INC. | 11/14/2025 | 79.03 K | $1.85 K | 100.00% | 0.85% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 62.50 K | $1.46 K | 0.00% | 0.67% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 26.30 K | $750 | 100.00% | 0.28% |
| UBS GROUP AG | 11/13/2025 | 23.41 K | $539 | 100.00% | 0.25% |
| WALLEYE TRADING LLC | 11/14/2025 | 11.44 K | $268 | -64.11% | 0.12% |
| WOLVERINE ASSET MANAGEMENT LLC | 10/28/2025 | 1.81 K | $42 | -60.80% | 0.02% |
| NEWEDGE ADVISORS, LLC | 11/17/2025 | 1.07 K | $25 | 0.00% | 0.01% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 200 | $5 | 100.00% | 0.00% |
| TORONTO DOMINION BANK | 11/14/2025 | 200 | $5 | 100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
SAB Biotherapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 11 institutional investors and hedge funds held shares of SAB Biotherapeutics, Inc.. The most heavily invested institutionals were:
LMR Partners LLP: 539,588
MORGAN STANLEY: 146,439
Clear Street Group Inc.: 79,033
SUSQUEHANNA INTERNATIONAL GROUP, LLP: 26,302
UBS Group AG: 23,414
Walleye Trading LLC: 11,436
8.92% of SAB Biotherapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 908.33 K shares in the last 24 months. This purchase volume represents approximately $27.25 K in transactions.